Gerardo Cornelio

1.8k total citations · 1 hit paper
18 papers, 1.3k citations indexed

About

Gerardo Cornelio is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gerardo Cornelio has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Gerardo Cornelio's work include Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Genomics and Diagnostics (4 papers). Gerardo Cornelio is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Cancer Genomics and Diagnostics (4 papers). Gerardo Cornelio collaborates with scholars based in Philippines, Singapore and China. Gerardo Cornelio's co-authors include Sankar Srinivasan, Pan‐Chyr Yang, Yuankai Shi, Joseph S. K. Au, Sumitra Thongprasert, Chun‐Ming Tsai, Mai Trong Khoa, Y. Itoh, John Levy and Frederick L. Hall and has published in prestigious journals such as Journal of Clinical Oncology, European Heart Journal and British Journal of Cancer.

In The Last Decade

Gerardo Cornelio

16 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

2014 1.1k citations Yuankai Shi, Joseph S. K. Au et al. Journal of Thoracic Oncology profile →

Peers

Gerardo Cornelio

PRM

ONCOL

RNMI

Tatsuro Fukuhara Japan

J.M.G.H. van Riel Netherlands

Alexandra Voutsina Greece

Aleksandra Markovets United States

Annick Haller Belgium

Jaromı́r Roubec Czechia

Reiko Kaji Japan

Danilo Rocco Italy

Erina Hatashita Japan

Sankar Srinivasan India

Tatsuro Fukuhara Japan

Gerardo Cornelio

1.1k ×1.1

PRM

1.1k ×1.4

ONCOL

445 ×1.4

318 ×1.1

68 ×0.8

RNMI

Citations per year, relative to Gerardo Cornelio Gerardo Cornelio (= 1×) peers Tatsuro Fukuhara

Countries citing papers authored by Gerardo Cornelio

Since Specialization

Citations

This map shows the geographic impact of Gerardo Cornelio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerardo Cornelio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerardo Cornelio more than expected).

Fields of papers citing papers by Gerardo Cornelio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerardo Cornelio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerardo Cornelio. The network helps show where Gerardo Cornelio may publish in the future.

Co-authorship network of co-authors of Gerardo Cornelio

This figure shows the co-authorship network connecting the top 25 collaborators of Gerardo Cornelio. A scholar is included among the top collaborators of Gerardo Cornelio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerardo Cornelio. Gerardo Cornelio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cornelio, Gerardo, et al.. (2022). P28-10 Survival difference between EGFR exon 19 deletion and exon 21 mutation in advanced non-small cell lung cancer patients. Annals of Oncology. 33. S523–S523. 1 indexed citations

Cornelio, Gerardo, et al.. (2020). Cytokines as a prognostic biomarker of overall survival in pancreatic cancer.. Journal of Clinical Oncology. 38(15_suppl). e16753–e16753. 2 indexed citations

Cornelio, Gerardo, et al.. (2020). Clinical outcomes of chemotherapy-induced subclinical left ventricular systolic dysfunction among breast cancer patients detected using echocardiographic global longitudinal strain. European Heart Journal. 41(Supplement_2).

Sacdalan, Danielle Benedict, et al.. (2020). Medical oncology care amidst the COVID-19 pandemic at the National University Hospital in the Philippines. ecancermedicalscience. 14. 1066–1066. 8 indexed citations

Kim, Sung‐Bae, In‐Gu Do, Janice Tsang, et al.. (2019). BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy. Cancer Research and Treatment. 51(4). 1527–1539. 5 indexed citations

Cheng, Ann‐Lii, Gerardo Cornelio, Lin Shen, et al.. (2016). O-015 Association between depth of response (DpR) and survival outcomes in RAS-wild-type (wt) patients with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab once-every-2-weeks in the APEC study. Annals of Oncology. 27. ii123–ii123. 1 indexed citations

Cornelio, Gerardo, María Tamayo, Michele Gargano, et al.. (2016). BTH1677 in combination with cetuximab with and without irinotecan in patients with advanced metastatic colorectal cancer. 5(3). 95–108. 4 indexed citations

Cheng, Ann‐Lii, Gerardo Cornelio, Lin Shen, et al.. (2015). Final analysis of the phase 2 APEC study: Overall survival (OS) data and biomarker subanalyses for first-line FOLFOX or FOLFIRI with cetuximab (cet) once every 2 weeks in patients (pts) with KRAS or RAS (KRAS and NRAS, exons 2-4) wild-type (wt) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 33(3_suppl). 566–566. 1 indexed citations

Shi, Yuankai, Joseph S. K. Au, Sumitra Thongprasert, et al.. (2014). A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER). Journal of Thoracic Oncology. 9(2). 154–162. 1105 indexed citations breakdown →

10.

Cheng, Ann‐Lii, Gerardo Cornelio, Lin Shen, et al.. (2013). First-Line Cetuximab with Folfox or Folfiri Every 2 Weeks in Kras Wild-Type Metastatic Colorectal Cancer: Phase II Apec Study. Annals of Oncology. 24. iv34–iv35. 4 indexed citations

11.

Yap, Yoon Sim, Gerardo Cornelio, Chonlakiet Khorprasert, et al.. (2012). Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival. British Journal of Cancer. 107(7). 1075–1082. 42 indexed citations

12.

Yang, Pan‐Chyr, Yuankai Shi, Joseph S. K. Au, et al.. (2012). Molecular epidemiological prospective study of EGFR mutations from Asian patients (pts) with advanced lung adenocarcinoma (PIONEER).. Journal of Clinical Oncology. 30(15_suppl). 1534–1534. 9 indexed citations

13.

Cornelio, Gerardo, et al.. (2010). A phase Ib/II, dose-escalating, safety, and efficacy study of imprime PGG and cetuximab in patients with advanced colorectal cancer (CRC).. Journal of Clinical Oncology. 28(15_suppl). e14103–e14103. 3 indexed citations

14.

Tamayo, María, et al.. (2009). A phase Ib/2, dose-escalating, safety, and efficacy study of imprime PGG, cetuximab and irinotecan in patients with advanced colorectal cancer (CRC). Journal of Clinical Oncology. 27(15_suppl). e15062–e15062. 7 indexed citations

15.

Cornelio, Gerardo, et al.. (2008). Phase I study of sequential targeted gene delivery: Intravenous infusions of Rexin-G followed by Reximmune-C induce tumor necrosis and recruitment of tumor infiltrating lymphocytes in cancerous lesions. Journal of Clinical Oncology. 26(15_suppl). 3077–3077. 1 indexed citations

16.

Gordon, Erlinda M., Francisco Lopez, Gerardo Cornelio, et al.. (2007). Le morte du tumour: Histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes. International Journal of Oncology. 30(6). 1297–307. 16 indexed citations

17.

Gordon, Erlinda M., Francisco Lopez, Gerardo Cornelio, et al.. (2006). Pathotropic nanoparticles for cancer gene therapy Rexin-G™ IV: Three-year clinical experience. International Journal of Oncology. 29(5). 1053–64. 29 indexed citations

18.

Gordon, Erlinda M., et al.. (2004). First clinical experience using a ‘pathotropic’ injectable retroviral vector (Rexin-G) as intervention for stage IV pancreatic cancer. International Journal of Oncology. 24(1). 177–85. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact